Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

Sectors: Startup accelerator & VC

Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS …

Sectors: Research

Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is …

Sectors: Biotechnology

[Automatic translation follows] Prevention / Care / Research / Teaching, serving patients with #cancer. Gustave Roussy, the leading cancer center in Europe, 4th best cancer hospital in the world, constitutes a global center of expertise against cancer, serving patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Grand Paris). A private establishment of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and teaching

Sectors: Health

Startup incubator and entrepreneurship and innovation center of the Ecole polytechnique Since 1794, the École Polytechnique has been training engineers to the highest level. The scientific and technological dimension combined with a unique ecosystem allow the school to support and incubate some of the most innovative technological start-ups in the country. With our X-Up programs, X-Fab and support services, our vocation is to meet all the needs of innovation players thanks to our accelerator and incubator, as well as financing tools, coworking and prototyping spaces to encourage creativity and the emergence of high-potential entrepreneurial projects.

We aspire to be the premier research-intensive biopharmaceutical company. At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of …

Sectors: Pharmaceutical